ABSTRACT: Calcium phosphate cements (CPCs) are widely used for bone-defect treatment. Current developments comprise the fabrication of porous scaffolds by three-dimensional plotting and doting using biologically active substances, such as strontium. Strontium is known to increase osteoblast activity and simultaneously to decrease osteoclast resorption. This study investigated the short-and long-term in vivo performances of strontium(II)-doted CPC (SrCPC) scaffolds compared to non-doted CPC scaffolds after implantation in unloaded or load-bearing trabecular bone defects in sheep. After 6 weeks, both CPC and SrCPC scaffolds exhibited good biocompatibility and osseointegration. Fluorochrome labeling revealed that both scaffolds were penetrated by newly formed bone already after 4 weeks. Neither strontium doting nor mechanical loading significantly influenced early bone formation. In contrast, after 6 months, bone formation was significantly enhanced in SrCPC compared to CPC scaffolds. Energy dispersive X-ray analysis demonstrated the release of strontium from the SrCPC into the bone. Strontium addition did not significantly influence material resorption or osteoclast formation. Mechanical loading significantly stimulated bone formation in both CPC and SrCPC scaffolds after 6 months without impairing scaffold integrity. The most bone was found in SrCPC scaffolds under load-bearing conditions. Concluding, these results demonstrate that strontium doting and mechanical loading additively stimulated bone formation in CPC scaffolds and that the scaffolds exhibited mechanical stability under moderate load, implying good clinical suitability. ß
Calcium phosphate cements (CPCs) are synthetic bone grafts, which have been widely used for many years to fill bone defects caused by fracture or after tumor resection, to reinforce osteoporotic bone, and to augment metallic implants in weak bone. [1] [2] [3] In general, preparation is based on mixing one or more calcium orthophosphate powders with aqueous liquids. During preparation and/or after implantation in vivo, the resulting moldable paste hardens during a low-temperature self-setting reaction to form a solid calcium phosphate body of either apatite or brushit, depending on the formulation of the starting calcium phosphate salts and the reaction conditions. 1 CPCs exhibit excellent biocompatibility and bioactivity, and integrate well in bony host tissue. 2 Depending on their compositional and microstructural features, CPCs are able to degrade in vivo by passive physicochemical dissolution and/or undergo active cellular resorption. 4, 5 An important advantage of CPCs is the option of minimally invasive application into irregular bone defects, including vertebroplasty and bone-void filling in closed fracture sites. 6, 7 In this context, so-called ready-to-use CPCs exhibit unique handling features because they are manufactured to form long-term stable pastes using non-aqueous liquid. The setting reaction does not start until the substitution of the carried liquid by body fluid after implantation. 8 CPCs can also be processed by additive manufacturing techniques to produce three-dimensional (3D) scaffolds with defined shape and with remarkable reproducibility. [9] [10] [11] These techniques are highly attractive in allowing very flexible fabrication of scaffolds with specific design and structural features to meet the requirements of certain target indications and for tissue engineering approaches or even patient-specific implants. The capability of designing interconnecting macropores allows for rapid cell colonization, vessel formation, and bone ingrowth. Conventional manufacturing routes mostly include 3D powder printing, severe heat treatment, and post-processing, for example, milling and grinding. 12 Sintering steps, however, limit the applicability of mineral components, lead to a coarsening of crystal structures, and prevent the embedding of organic substances during the manufacturing process. A novel 3D plotting technique based on the above-mentioned ready-to-use CPC paste has been developed under the participation of authors of the present study. 11 The route allows processing of porous scaffolds from an injectable CPC under mild conditions, thereby avoiding coarsening of the crystalline structure due to sintering processes and offers the option to add biologically active components during the manufacturing process. 8 The CPC scaffold produced by this technique was shown to exhibit adequate mechanical performance and biocompatibility in vitro, 11 and was well osseointegrated in vivo in a calvarial bone-defect model in sheep.
Loading of the CPC with bone morphogenetic protein-2, a potent osteoinductive growth factor, promoted accelerated bone formation and maturation. 14 As an alternative to bioactive growth factors, doting CPCs with strontium(II) (Sr 2þ ) was introduced to support especially the regeneration of osteoporotic bone defects. 15, 16 This approach may be advantageous compared to growth factors due to lower costs, better stability, and, particularly, long-term availability. Strontium is successfully used as oral medication in the treatment of osteoporosis, because it exerts a dual effect on bone remodeling: It stimulates bone formation by increasing osteoblast proliferation and activity and simultaneously inhibits bone resorption by reducing osteoclast differentiation and function. 17, 18 Although the molecular mode of action is not completely understood, it is generally accepted that strontium exerts its action mainly by the activation of the calcium-sensing receptor, thereby modulating several crucial downstream pathways, which regulate bonecell activity, including the potent osteoanabolic Wntsignaling pathway. 17, 18 In vivo evaluation of bone grafts requires clinically relevant load-bearing defect models, because mechanical loading is an important regulator of bone regeneration and implant osseointegration. [19] [20] [21] The ingrowth of newly formed bone in porous scaffolds is strongly influenced by the mechanical environment of the defect region. [22] [23] [24] An additional aspect to be considered in implantation models is the possible structural disintegration of scaffolds under long-term in vivo loading. Due to their limited mechanical properties, ceramic scaffolds in particular cannot withstand high mechanical loads. [1] [2] [3] To address these aspects, our group established a defect model within load-bearing regions of the trabecular bone in sheep, which enables evaluation of the performance of bone grafts under well-defined loading conditions. [25] [26] [27] [28] Based on previous work, 8, 11 the present study investigated the effect of strontium doting on the early and long-term in vivo performances of porous 3D printed CPC scaffolds. Furthermore, we examined whether the scaffolds can withstand moderate loading and whether new bone formation in the scaffolds is influenced by mechanical stimuli by using a loadbearing defect model in the tibia metaphysis in comparison to an unloaded defect model in the femoral condyle of sheep.
MATERIALS AND METHODS

Preparation of Cement Scaffolds
The CPC paste was prepared as described previously. 8, 16 In brief, cement powder components (60 wt% a-tricalcium phosphate (a-Ca 3 (PO 4 ) 2 ), 26 wt% calcium hydrogen phosphate (monetite, CaHPO 4 ), 10 wt% calcium carbonate (CaCO 3 ), 4 wt% precipitated hydroxyapatite (Ca 10 (PO 4 ) 6 (OH) 2 )) with the addition of 2.5% finely ground potassium hydrogen phosphate (K 2 HPO 4 ) were mixed followed by paste formation by adding carrier liquid consisting of short-chain triglyceride (Miglyol 812, C€ asar and Loretz, Hilden, Germany), castor oil ethoxylate 35 (Cremophor ELP, BASF, Ludwigshafen, Germany), and hexadecyl phosphate (Cetyl-phosphate, Amphisol A, Brenntag AG, M€ uhlheim an der Ruhr, Germany). The powder to liquid ratio was 6:1. The strontium(II)-doted calcium phosphate cement (SrCPC) paste was obtained by complete substitution of the CaCO 3 component by strontium carbonate (SrCO 3 ) in the powder phase, resulting in a Sr/Ca ratio of 0.123. After complementing the powder mixture with potassium hydrogen phosphate, the paste was produced by adding the carrier liquid as indicated above. The substitution of calcium by strontium did not affect the setting behavior of the paste. The increase of compressive strength as sign of the proceeding cement reaction was similar during setting and reached the typical plateau. The homogeneous paste was filled into 10-ml plotting cartridges (Nordson, Dettingen unter Teck, Germany) equipped with a 0.41-mm dosage needle (Nordson). A Discovery 3D plotter (regenHU, Villaz-St-Pierre, Switzerland) was used for scaffold manufacture. The scaffold design was based on meandering steering of the dosage needle generating the footprint of the implant. Three-dimensional expansion was facilitated by alternating orthogonal layers. The strand diameter correlated to the dosage needle used and porosity was determined by applying a strand distance of 0.59 mm. Implant designs were cylindrical (diameter 9.2 mm, height 15 mm) or wedgeshaped (orthogonal legs of 24 and 14 mm, height 6 mm) (Fig. 1) . Directly after completing the printing process, cement setting was performed by incubating the scaffolds at 95% relative humidity at 50˚C for 4 days. This manufacturing route ensures that neither mineral ions are released or leached out from the scaffolds nor degradation processes occur prior implantation. The identical manufacturing routine was applied for CPC and SrCPC scaffolds as well as for the two scaffold designs, generating four different implant types (Fig. 1) . The macroporosity of the printed scaffolds was 50%. Mechanical characterization of the scaffolds was performed by using an Inspekt 20 table blue testing machine (Hegewald & Peschke, Germany) at fixed 1 mm s À1 crosshead speed. Compressive strength was calculated from force and corresponding displacement. The ultimate compression strength in the z-direction of the scaffolds-defined by the horizontal layering-was 10 MPa for the CPC scaffolds and 18 MPa for the strontium-modified version as a result of Srsubstituted hydroxyapatite formation.
Design of the In Vivo Study
The animal study was approved by the Local Ethical Committee (Regierungspr€ asidium T€ ubingen, Germany, No. 1142) and was in compliance with international recommendations for care and use of laboratory animals (ARRIVE guidelines and EU Directive 2010/63/EU for animal experiments). In total, 14 adult female merino sheep (3-5 years, 70-110 kg) were used for the study. All sheep underwent bilateral surgery and received both materials. CPC was implanted in the right hind limb and SrCPC in the left hind limb. Each hind limb underwent surgery at two sites to compare the performance of materials under different load-bearing conditions. The materials were implanted in a non-load-bearing situation in a drillhole defect in the distal femoral condyle as well as in an established weight-bearing defect model in the proximal tibia metaphysis ( Figs. 1 and 2) . 5, 25, 29, 30 In previous studies, both bone-defect models were proven to be of critical size and did not heal during the observation period. 5, 25, 28 Therefore, empty defects were omitted in the present study to reduce STRONTIUM AUGMENTS BONE-DEFECT HEALING the number of animals. After 6 and 26 weeks, sheep were sacrificed (n ¼ 7 per group) and the femora and tibia were collected and processed for histological and energy dispersive X-ray (EDX) analyses. , VeyxPharma GmbH, Schwarzenborn, Germany) subcutaneously for antibiotic prophylaxis for 4 days. CPC and SrCPC scaffolds were implanted in the left and right hind limb, respectively. The surgical procedure was described in detail previously. 5, 25 The cylindrical scaffold was used in unloaded defect in the femur, whereas the wedge-shaped scaffold was used in load-bearing defect in the tibia. Briefly, after a medial approach, a hole with 10-mm diameter and 15-mm depth was drilled into the trabecular bone of the femoral condyle. A wedge-shaped defect (width 14, length 24, height 6 mm) was created in the trabecular bone 3 mm distal of the medial tibia plateau. The defects were carefully cleaned of bone debris by flushing with sterile saline and the implants were press-fit inserted. For labeling of newly formed bone, tetracycline hydrochloride (25 mg kg À1 body weight) and calcein green (10 mg kg À1 body weight) were i.v. injected 2 and 4 weeks after surgery, respectively, if the sheep were sacrificed after 6 weeks. In the 26-week group, tetracycline and calcein green were administered 8 and 16 weeks after surgery, respectively.
Surgical Procedure
Histological Evaluation
The implants with approximately 10 mm of surrounding bone were explanted and processed for histology. The implants Figure 1 . Images of the cylindrical and wedgeshaped cement scaffolds used for implantation. The lateral (A) and top (B) aspects show the accurate strut deposition and the continuous porosity of the scaffolds. The cylindrical scaffold was used in unloaded defect in the femur, whereas the wedgeshaped scaffold was used in load-bearing defect in the tibia. were divided into two parts. One part was used for nondecalcified histology, whereas the other part was used for decalcified histology. For non-decalcified histology, the specimens were incubated in 4% buffered formaldehyde for fixation, dehydrated in an ascending series of ethanol, and embedded in methyl methacrylate (Merck KGaA, Darmstadt, Germany). Several 70-mm slices were prepared and stained with Paragon (Paragon C&C, New York, NY) according to standard protocols. The samples were evaluated in a blinded fashion. They were scanned at 50-fold magnification under light microscopy (Leica DMI6000B, Software MMAF Version 1.4.0 MetaMorph 1 , Leica, Heerbrugg, Switzerland). For image analysis, Photoshop (Adobe Systems, Mountain View, CA) and MATLAB 1 (MATLAB R2009b, The MathsWorks, Inc., Natick, MA) were used. The entire implant area was defined as the "region of interest." The relative areas of cement, bone, and connective tissue (Cm.Ar/T.Ar, B.Ar/T.Ar, and FT.Ar/T.Ar, respectively) as well as the relative bone-toimplant contact surface (B.Pm/Cm.Pm) were determined. The spatial distribution of the tetracycline-labeled (yellow) and calcein-labeled (green) bone was analyzed in the methyl methacrylate-embedded slices under fluorescent light (filter cubes LED 405 and L5 ET for excitation wavelength of 402 and 494 nm, respectively, both from Leica) to qualitatively evaluate the time-course of implant bone ingrowth.
For decalcified histology, specimens were decalcified for 3 months in EDTA, and then embedded in paraffin as described previously. 31 Osteoclasts were identified using histochemical staining for tartrate-resistant acid phosphatase (TRAP). Cells with !3 nuclei, residing on the bone or cement surface, and being positive for TRAP staining were defined as osteoclasts. Cells were counted in six visual fields (approximately 8 mm 2 ) under 100-fold magnification in the central area of the implant.
EDX Analysis
To investigate the strontium content in the scaffolds, the methyl methacrylate-embedded samples were polished and carbon coated (MED 010, Balzers Union, Dietenheim, Germany). EDX analysis was performed using a Zeiss DSM 962 scanning electron microscope (Zeiss, Jena, Germany) and Genesis Line/Map 6.44 software (EDAX, Weiterstadt, Germany). The spectral maps were recorded at an acceleration voltage of 20 kV.
Statistics
Differences between the 6-and 26-week groups were identified using the non-parametric, two-sample Mann-Whitney U-test. To evaluate differences within one implantation period (CPC vs. SrCPC; non-load-bearing vs. load-bearing conditions), significance was tested using the unpaired, twosample Wilcoxon signed rank test. Statistics were performed using SPSS software (v21, SPSS Inc., Chicago, IL). The level of significance was set at p 0.05. The results are presented as the means and standard deviations.
RESULTS
Clinical Observations
The surgical intervention was well tolerated by the sheep. The animals showed a normal walking pattern after implantation as determined by visual examination by experienced veterinarians, and exhibited uneventful wound healing. There were no macroscopically visible signs for tissue infection or inflammation of the tissue when the implants were retrieved after 6 and 26 weeks.
Osseointegration of the CPC Scaffold Under Non-Load-Bearing Conditions
Six weeks after implantation in the unloaded femoral drill hole, the CPC scaffolds without strontium were well integrated in newly formed bone (Fig. 3) . The bone near and inside the implant was vital and no inflammatory cells were observed. The pores inside the CPC scaffold were filled predominantly with loose soft tissue containing large numbers of blood vessels. Thin layers of newly formed bone covered the pore walls inside the entire scaffold. Histomorphometrical quantification demonstrated 9 AE 2% of the scaffold area to be newly formed bone (Fig. 4) . Tight bone contact was exhibited by 66 AE 8% of the pore walls. Tetracycline labeling performed at 2 weeks revealed that new bone was formed mostly in the outer regions of the scaffolds, whereas less tetracycline-labeled bone was found in the center of the implant (Fig. 5) . Calcein-greenlabeled bone was found both in the inner and outer regions of the implants, indicating that the scaffold was entirely penetrated by newly formed bone after 4 weeks, when the fluorochrome was applied. After 26 weeks, no significant changes were observed for the relative bone area, soft tissue area, or material/bone contact surface compared to the 6-week time point (Figs. 6 and 7 ). This was confirmed by the evaluation of tetracycline and calcein-green labeling, which was performed after 8 and 16 weeks, respectively. Yellow tetracycline bands were found closer to the material surface than green calcein bands, indicating that the bone, which was formed later, was primarily deposited on elder bone and not on the remaining uncovered pore walls (Fig. 5) . The relative implant area was not significantly altered after 26 weeks compared to 6 weeks, suggesting that there was no significant material degradation during the observation period (Fig. 7) .
Influence of Strontium Doting
After 6 weeks, strontium doting of the materials had no significant influence on bone formation (Figs. 3  and 4) . The relative amount of bone and the fraction of the pore walls covered with bone did not significantly differ between the SrCPC and CPC scaffolds. In contrast, 26 weeks after implantation, the relative bone area was significantly increased in the SrCPC scaffold compared to the CPC scaffold both in the femoral and the tibial defects (Figs. 6 and 7) . While the bone layers formed on the surface of the SrCPC scaffolds were thicker, the relative material surface covered with bone was not significantly affected by strontium doting (Figs. 3, 6, and 7) . We found no differences in the amount and distribution of fluorochrome labeling of the newly formed bone between the SrCPC and CPC groups after 6 weeks. Additionally, STRONTIUM AUGMENTS BONE-DEFECT HEALING the implant area was not significantly altered both in the femoral and tibial SrCPC implants compared to CPC scaffolds, indicating that strontium doting did not significantly alter material degradation behavior (Fig. 7) . This was confirmed by the evaluation of TRAP-positive, multinuclear osteoclast-like cells. Osteoclasts were found in both the CPC and SrCPC scaffolds near the material surface, indicating that both cements were slowly resorbed during the remodeling process, but neither the amount nor the size of the osteoclasts were affected by the addition of strontium (Fig. 8) . EDX analysis revealed that 26 weeks after implantation, SrCPC contained approximately 10 wt% of strontium. The bone at some distance from the implant contained 2.5 wt% of Sr. The bone in close proximity to the SrCPC scaffold surface revealed an increased strontium content of approximately 5.3 wt% (Fig. 9) .
Influence of Load Bearing
To investigate the influence of mechanical loading, the scaffolds were inserted in a femoral drill-hole defect and in a load-bearing bone defect located at the tibia metaphysis. Six weeks after implantation we detected no significant influence of loading on new bone formation and distribution within the CPC and SrCPC scaffolds (Figs. 3 and 4) . In contrast, after 26 weeks, bone formation was significantly increased under loadbearing conditions (Figs. 6 and 7) . In the loaded CPC and SrCPC scaffolds, the bone area was significantly increased by 90% and 50%, respectively. The proportion of the materials surface covered with bone was 
DISCUSSION
The present study investigated the short-and longterm performances of strontium-doted SrCPC scaffolds compared to non-doted CPC scaffolds both under mechanically unloaded and loaded conditions in trabecular bone regions in sheep. The results demonstrated that the addition of strontium effectively improved bone formation after an implantation period of 6 months and did not influence material degradation. Moderate weight bearing did not impair scaffold integrity but favored bone formation in both CPC and SrCPC scaffolds. The greatest bone formation was found in SrCPC scaffolds implanted under load-bearing conditions.
The scaffolds used in the present study were fabricated on the basis of an injectable ready-to-use CPC paste 8 by 3D-plotting and solidification of the printed structures by the cement-setting reaction being under mild conditions. 11 In the present study, we evaluated lattice-like structures with an interconnecting porosity of approximately 50% and a pore size of approximately 590 mm, because pore sizes in this range are in general regarded to support tissue and blood vessel ingrowth as well as bone formation. 32, 33 Confirming recent in vivo studies using scaffolds made from the same CPC but with slightly different structures, 13 the present results revealed excellent biocompatibility of the non-doted CPC scaffolds. The CPC scaffolds were well osseointegrated and penetrated by newly formed bone. New bone had already entered the scaffold 2 weeks after implantation. After 4 weeks, bone was deposited in the center of the scaffolds and after 6 weeks, thin bone layers covered approximately 60% of the pore walls throughout the entire implant, confirming the excellent osteoconductive properties of the applied CPC composition. After 6 months, the new bone inside the scaffolds was maintained but its amount did not further increase, suggesting that the maximum capacity of the non-doted CPC scaffolds to stimulate bone formation was achieved within a few weeks.
To stimulate increased and sustained bone formation, we doted the CPC scaffolds with strontium, which provokes osteoanabolic effects both by enhancing osteoblast activity and inhibiting osteoclast activity. 17, 18 Through osteoclast inhibition, strontium doting might be particularly attractive for the treatment of bone defects in postmenopausal osteoporosis, which is associated with increased osteoclast activity. 34 Indeed, several experimental studies demonstrated that the local release of strontium from CPCs of different 
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compositions stimulated bone-defect healing both in healthy 35, 36 and osteoporotic animals. 16 In the present study, the addition of strontium did not further accelerate or increase early bone ingrowth beyond the already high level of plain CPC. In contrast, strontium doting did remarkably lead to a considerably enhanced bone content after 6 months, probably as a result of maintaining a continuous bone-forming stimulus. The analysis of the strontium concentrations by EDX demonstrated increased strontium concentrations in the newly formed bone near the material surface, suggesting that the increased bone formation was due to strontium release. Notably, the bone layers covering the pore walls considerably thickened in SrCPC scaffolds with time without increasing the surface fraction covered with bone compared to the non-doted CPC implants. This might be explained by the mode of action of strontium, which, in particular, activates osteoblast differentiation, matrix production, and survival, 17 ,18 but probably does not increase the attraction of osteoblastic precursor cells to the SrCPC surface. The number of bone-resorbing osteoclasts on the material surface and the adjacent bone was unaffected by strontium doting, suggesting that SrCPC did not suppress osteoclast formation. This observation is in line with a recent in vitro study reporting that osteoclast formation remained unaffected whereas osteoclast resorption activity was inhibited when the cells were cultivated on SrCPC discs. 37 Concluding, the present study demonstrated that strontium doting provoked a significant and sustainable stimulating effect on bone formation.
We did not detect a significant material degradation in the CPC scaffold after 6 months. This confirms previous in vivo study with similar scaffolds. 13 Furthermore, strontium doting also did not affect material degradation and scaffold stability in our study. It was reported that the addition of strontium could influence both physicochemical dissolution and cellular degradation of CPC, depending on the specific material formulation. 15 However, in vivo data comparing strontium-doted with non-doted cements are currently limited. Some studies reported enhanced cement degradation after strontium doting, but the underlying mechanisms remain unclear and require further investigation. 16, 38, 39 In general, the clinical application of CPCs is restricted to unloaded or moderately weight-bearing bone-defect regions due to their limited mechanical properties, particularly high brittleness. [1] [2] [3] The introduction of pores by 3D printing inevitably further reduces the mechanical strength compared to compact CPC samples. Regarding the scaffolds used in the present study, the in vitro ultimate compression strength was 10 MPa for the CPC scaffold and 18 MPa for the SrCPC scaffold at a macroporosity of 50%. These values are of the same order of magnitude as reported for powder-printed and sintered CPC scaffolds. 40, 41 To assess the resistance of the scaffolds to moderate weight bearing in vivo, we used a loaded trabecular bone-defect model in the metaphysis of the sheep tibia. 26, 28 Implants inserted in this defect are predominantely loaded by cyclic compression during walking of the sheep. Peak compression stresses of approximately 5 MPa were calculated using a finite element model, 28 whereas the in vitro determined compression strength for both materials was 10 and 18 MPa, respectively. We could not detect any deformation or disintegration of the scaffolds in the histological sections, suggesting that they were able to resist immediate postoperative loading in the model used. The mechanical properties most probably improved continuously with increasing bone content, resulting in a material-bone composite with an even lower risk of failure at later implantation time points. Therefore, the scaffolds exhibited sufficient mechanical 
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stability during surgical handling and in moderately loaded bone defects. Any clinical application in higher load-bearing areas would certainly require additional support by osteosynthetic implants.
It is generally accepted that moderate mechanical strain stimulates bone formation, whereas low or no strain provokes no or even negative effects. 20, 21, 42 Therefore, it is proposed that the elastic properties of porous scaffolds should ideally match those of the surrounding bone to avoid stress shielding, which could hamper new bone formation and/or maintenance inside the pores. 22, 43 Compared to trabecular bone, the CPC and SrCPC scaffolds exhibit a higher elastic modulus due to their pure mineral nature and might, therefore, not elastically deform under cyclic loading of the bone defect. 11 Nevertheless, weight bearing significantly enhanced bone formation both in the CPC and SrCPC scaffolds during the late implantation period. Loading of the scaffolds most probably induces additional mechanical effects inside the scaffold pores, including hydrodynamic stimuli, which support bone formation. 44 Furthermore, even though we observed no cracks, the scaffolds' structures could be weakened with time, thereby transferring mechanical stimuli to the newly formed bone inside the scaffold. This hypothesis is supported by the observation that bone ingrowth was enhanced under load-bearing conditions only after the longer implantation period.
A limitation of our study might be that we did not measure the mechanical properties of the scaffolds after explanation. However, only the material/bone composite can be evaluated by such measurements. Therefore, it is not possible to discriminate between the cement and the ingrown bone.
In our study, most bone was found in the weightbearing SrCPC scaffolds, indicating an additive effect of strontium doting and mechanical stimulation. This is confirmed by an in vitro study demonstrating that strontium influenced the mechanically induced release of important signaling molecules from osteocytes regulating bone turnover, including nitric oxide and prostaglandin E2. 45 It appears likely that strontium influences mechanically induced bone formation, because strontium and mechanical stimuli share several intracellular pathways. For example, both increase intracellular calcium concentrations and activate MAPK/ERK and Wnt signaling. 17, 18, 46, 47 However, further investigations are required to elucidate the mechanisms underlying the interaction of strontium and mechanical loading observed in the present study.
CONCLUSION
We demonstrated that 3D printed porous scaffolds fabricated on the basis of an injectable ready-to-use CPC paste exhibited excellent biocompatibility and osseointegration. Furthermore, the scaffolds exhibited sufficient mechanical stability after implantation in a moderately load-bearing defect model. Strontium doting resulted in improved and sustained long-term bone formation in the scaffolds, which may be advantageous compared to growth factors with limited biological half-life. These results implicate that the scaffolds might be suitable for clinical application, particularly in osteoporotic bone.
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